Request Demo
Last update 20 Mar 2025
Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Non-recombinant coagulation factor |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (05 Sep 2019), |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd)CTR20160937
目标值法验证人凝血酶原复合物治疗乙型血友病的有效性及安全性的单臂开放多中心临床研究
[Translation] A single-arm open-label multicenter clinical study to verify the efficacy and safety of human prothrombin complex therapy in the treatment of hemophilia B using the target value method
CTR20131251
评价人凝血酶原复合物治疗血友病B的有效性与安全性的单臂、开放性、多中心临床试验
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the efficacy and safety of human prothrombin complex therapy in the treatment of hemophilia B
100 Clinical Results associated with Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd)
Login to view more data
100 Translational Medicine associated with Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd)
Login to view more data
100 Patents (Medical) associated with Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd)
Login to view more data
100 Deals associated with Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hemorrhage | China | 05 Sep 2019 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia B | Phase 1 | China | 06 Jun 2013 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free